Search Results - "Zieglmayer, R."

Pru p 3, a marker allergen for lipid transfer protein sensitization also in Central Europe by Mothes‐Luksch, N., Raith, M., Stingl, G., Focke‐Tejkl, M., Razzazi‐Fazeli, E., Zieglmayer, R., Wöhrl, S., Swoboda, I.

“…In the Mediterranean area, lipid transfer proteins (LTPs) are important causes of plant‐food allergies often associated with severe allergic reactions. There,…”
Get full text

Cetirizine inhibits gender-specific blood cell dynamics upon allergen contact in allergic rhinitis by Jordakieva, G., Kundi, M., Lemell, P., Zieglmayer, R., Zieglmayer, P., Jensen-Jarolim, E., Crevenna, R.

“…IgE-mediated inflammatory responses upon allergen contact in allergic rhinitis (AR) are associated with rapid alterations of circulating blood cell numbers…”
Get full text

The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trial by Horak, F., Zieglmayer, P., Zieglmayer, R., Lemell, P., Collins, L. P., Hunter, M. G., Steiner, J., Lewis, T., Payton, M. A., Perkins, C. M., Pettipher, R.

“…Background CRTH2 mediates activation of Th2 cells, eosinophils and basophils in response to prostaglandin D2. The CRTH2 antagonist OC000459 has previously been…”
Get full text

The improved efficacy of a fixed-dose combination of fluticasone furoate and levocabastine relative to the individual components in the treatment of allergic rhinitis by Murdoch, R. D., Bareille, P., Ignar, D., Miller, S. R., Gupta, A., Boardley, R., Zieglmayer, P., Zieglmayer, R., Lemel, P., Horak, F.

“…Summary Background Allergic rhinitis (AR) is a common chronic disease, which has significant detrimental effect on well‐being and quality of life as well as…”
Get full text

Changes in basophil activation during grass‐pollen sublingual immunotherapy do not correlate with clinical efficacy by Van Overtvelt, L., Baron‐Bodo, V., Horiot, S., Moussu, H., Ricarte, C., Horak, F., Zieglmayer, P., Zieglmayer, R., Montagut, A., Galvain, S., de Beaumont, O., Le Gall, M., Moingeon, P.

“…To cite this article: Van Overtvelt L, Baron‐Bodo V, Horiot S, Moussu H, Ricarte C, Horak F, Zieglmayer P, Zieglmayer R, Montagut A, Galvain S, de Beaumont O,…”
Get full text

Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration by Horak, Friedrich, Zieglmayer, Petra U., Zieglmayer, R., Kavina, A., Lemell, P.

“…Aims To compare the onset and duration of action of the new antihistamine levocetirizine with that of the second‐generation antihistamine fexofenadine using…”
Get full text

A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC) by Stübner, P., Zieglmayer, R., Horak, F.

“…SUMMARY Objective: The Vienna Challenge Chamber (VCC) is an established method for the controlled exposure of patients to specific allergens, used to make…”
Get full text

Intranasal Toll-like Receptor 8 Agonist (VTX-1463) Significantly Improves Symptoms of Allergic Rhinitis in a Randomized, Placebo-Controlled Trial by Horak, F, Zieglmayer, P, Zieglmayer, R, Lemell, P, Newkirk, M, Manjarrez, K, Randall, T.D, Hershberg, R

“…The primary efficacy endpoints were the average change over 6 hours of allergen exposure in Total Nasal Symptom Score (TNSS; the sum of scores for nasal…”
Get full text

Controlled comparison of the efficacy and safety of cetirizine 10 mg o.d. and fexofenadine 120 mg o.d. in reducing symptoms of seasonal allergic rhinitis by Horak, F, Stübner, P, Zieglmayer, R, Kavina, A, De Vos, C, Burtin, B, Donnelly, F

“…The efficacy, onset and duration of action and safety of cetirizine 10 mg o.d., fexofenadine 120 mg o.d., and placebo were compared in this…”
Get more information

Onset of Action of a Five Grass Pollen 300IR SLIT Tablet Evaluated in an Allergen Challenge Chamber (ACC) by Horak, F, Zieglmayer, P, Zieglmayer, R, Lemell, P, Montagut, A, Mélac, M, Galvain, S, Le Gall, M

“…The Vienna ACC was developed as a pharmacodynamic assessment tool with a controlled environment overcoming all problems of unpredictable pollen seasons with…”
Get full text

Efficacy and safety of ketotifen fumarate eye drops as adjunctive therapy to mometasone furoate nasal spray in subjects with seasonal allergic rhinoconjunctivitis by Horak, F., Stuebner, P., Zieglmayer, R., McWhirter, C.L., Gekkieva, M.

Get full text

P401 RAPID ONSET OF ACTION OF A NOVEL BUDESONIDE NASAL SPRAY IN GRASS POLLEN ALLERGIC RHINITIS by Zieglmayer, P., Lemell, P., Unger- Manhart, N., Goessl, A., Zieglmayer, R., Prieschl- Grassauer, E.

Get full text

P451 SUPER- AND NON/LOW-RESPONDERS AMONG SUBJECTS WITH ALLERGIC RHINOCONJUNCTIVITIS RECEIVING HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY TABLET by Nelson, H., Zieglmayer, P., Bernstein, D., Zieglmayer, R., Lemell, P., Nolte, H.

Get full text

Efficacy and safety of ketotifen eye drops as adjunctive therapy to mometasone nasal spray in subjects with seasonal allergic rhinoconjunctivitis by Horak, F, Stuebner, P, Zieglmayer, R, McWhirter, C L, Gekkieva, M

“…To compare the efficacy and safety of ketotifen 0.025% ophthalmic solution (one drop/eye) with placebo as adjunctive therapy to mometasone nasal spray (50…”
Get full text

Alleviation of Allergic Rhinoconjunctivitis Symptoms in Participants Treated with a 0.005% Tacrolimus Eye-Drop Solution by Sladek, Svenja, Unger-Manhart, Nicole, Siegl, Cornelia, Dellago, Hanna, Zieglmayer, Petra U, Lemell, Patrick, Savli, Markus, Zieglmayer, René, Geitzenauer, Wolfgang, Längauer, Matthias, Prieschl-Grassauer, Eva

“…This randomized, placebo-controlled, crossover, double-blind trial aimed to evaluate the efficacy and safety of Tacrosolv, a novel 0.005% tacrolimus eye-drop…”
Get full text

Clinical Validation of a house dust mite environmental challenge chamber model by Zieglmayer, P., MD, Lemell, P., PhD, Chen, K.W., PhD, Schmutz, R., MD, Zieglmayer, R, Pfaar, O., MD, Horak, F., MD, Vrtala, S., PhD

“…Unstructured abstract Mite allergy causes significant socioeconomic burden. Environmental allergen exposure can be difficult to assess, and topical challenge…”
Get full text

Carrageenan-Containing Nasal Spray Alleviates Allergic Symptoms in Participants with Grass Pollen Allergy: A Randomized, Controlled, Crossover Clinical Trial by Unger-Manhart, Nicole, Morokutti-Kurz, Martina, Zieglmayer, Petra U, Lemell, Patrick, Savli, Markus, Zieglmayer, René, Prieschl-Grassauer, Eva

“…Nonpharmacological, barrier-forming nasal sprays are used to manage symptoms of allergic rhinitis. We aim to evaluate the safety and effectiveness of Callergin…”
Get full text

The effects of a TRPV1 antagonist, SB-705498, in the treatment of seasonal allergic rhinitis by BAREILLE, Philippe, MURDOCH, Robert D, DENYER, Jane, BENTLEY, Jane, SMART, Kevin, YARNALL, Katy, ZIEGLMAYER, Petra, ZIEGLMAYER, René, LEMELL, Patrick, HORAK, Friedrich

“…Current pharmacotherapy for allergic rhinitis (AR) does not totally ameliorate all symptoms for all patients. Residual symptoms could be due to nasal neuronal…”
Get full text

Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen–induced allergic rhinitis in an allergen-exposure unit by Horak, Friedrich, Stübner, Ursula P., Zieglmayer, Rene, Harris, Alan G.

“…Background: Unlike many antihistamines, desloratadine can reduce nasal congestion in patients with seasonal allergic rhinitis (SAR). Objective: We compared the…”
Get full text

The CRTH 2 antagonist OC 000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo‐controlled, double‐blind trial by Horak, F., Zieglmayer, P., Zieglmayer, R., Lemell, P., Collins, L. P., Hunter, M. G., Steiner, J., Lewis, T., Payton, M. A., Perkins, C. M., Pettipher, R.

“…Abstract Background CRTH 2 mediates activation of Th2 cells, eosinophils and basophils in response to prostaglandin D 2 . The CRTH 2 antagonist OC 000459 has…”
Get full text